A bill to establish an interagency committee to coordinate activities of the Federal Government relating to biotechnology oversight, and for other purposes.

Bill 118 s 4428, also known as the Biotechnology Coordination Act, aims to create an interagency committee that will oversee and coordinate the various activities of the Federal Government related to biotechnology. The purpose of this committee is to ensure that all aspects of biotechnology oversight are effectively managed and regulated.

The bill outlines the composition of the interagency committee, which will consist of representatives from various federal agencies involved in biotechnology oversight, such as the Department of Agriculture, the Food and Drug Administration, and the Environmental Protection Agency. The committee will be responsible for developing a comprehensive strategy for regulating biotechnology, as well as coordinating efforts to address any potential risks or concerns associated with biotechnological advancements.

Additionally, the bill includes provisions for public input and transparency, requiring the committee to hold public meetings and provide regular updates on its activities. It also mandates the development of a national biotechnology strategy, which will outline the goals and priorities for biotechnology oversight in the United States. Overall, the Biotechnology Coordination Act seeks to streamline and improve the regulation of biotechnology at the federal level, ensuring that all relevant agencies are working together to address the challenges and opportunities presented by advancements in this field.